Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Advanced Income Statement 
Ma Kis
Aug 07, 2020 10:10PM ET
Yetkin, nice to see you here too :)
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
0.19600
+0.00600
+3.16%
Type:
Equity
Market:
United States
- Volume: 6,479
- Bid/Ask: 0.00000 / 0.00000
- Day's Range: 0.18756 - 0.19680
Provectus
0.19600
+0.00600
+3.16%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
PVCT Income Statement
Featured here, the Income Statement (earnings report) for Provectus Biopharmaceuticals Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
| Period Ending: | 2023 31/12 |
2023 30/09 |
2023 30/06 |
2023 31/03 |
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.121 | 0.07 | 0.162 | 0.205 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Cost of Revenue, Total | 0.408 | 0.343 | 0.41 | 0.539 | ||||||||||||||||||||||||||||||
| Gross Profit | -0.286 | -0.273 | -0.248 | -0.334 | ||||||||||||||||||||||||||||||
| Total Operating Expenses | 0.339 | 0.784 | 0.946 | 0.927 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Operating Income | -0.218 | -0.714 | -0.784 | -0.722 | ||||||||||||||||||||||||||||||
| Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
| Gain (Loss) on Sale of Assets | - | - | - | - | ||||||||||||||||||||||||||||||
| Other, Net | 0.446 | 0.062 | 0.051 | 0.105 | ||||||||||||||||||||||||||||||
| Net Income Before Taxes | -0.663 | -0.776 | -0.835 | -0.827 | ||||||||||||||||||||||||||||||
| Provision for Income Taxes | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income After Taxes | -0.663 | -0.776 | -0.835 | -0.827 | ||||||||||||||||||||||||||||||
| Minority Interest | - | - | - | - | ||||||||||||||||||||||||||||||
| Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
| U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income Before Extraordinary Items | -0.663 | -0.776 | -0.835 | -0.827 | ||||||||||||||||||||||||||||||
| Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income | -0.663 | -0.776 | -0.835 | -0.827 | ||||||||||||||||||||||||||||||
| Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
| Income Available to Common Excluding Extraordinary Items | -0.663 | -0.776 | -0.835 | -0.827 | ||||||||||||||||||||||||||||||
| Dilution Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Net Income | -0.663 | -0.776 | -0.835 | -0.827 | ||||||||||||||||||||||||||||||
| Diluted Weighted Average Shares | 419.52 | 419.52 | 419.5 | 419.5 | ||||||||||||||||||||||||||||||
| Diluted EPS Excluding Extraordinary Items | -0.002 | -0.002 | -0.002 | -0.002 | ||||||||||||||||||||||||||||||
| DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Normalized EPS | -0 | -0.001 | -0.001 | -0.001 | ||||||||||||||||||||||||||||||
* In Millions of USD (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Provectus Biopharmaceuticals Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Yetkin Belasan
Aug 07, 2020 10:10PM ET
yea Ma, looking in to hpw ı can recover my ***** up on boxl. :)
0
0
Ma Kis
Aug 07, 2020 10:10PM ET
Yetkin Belasan I'm not sure that PVCT is a good option for a short time investment.
I'm long in PVCT since 2017 (when it was 0.03 per share). It's a very volatile stock, but the price began spiking during the last month. Soy I wouldn't short it before seeing the earning report (supposed to be published on Wednesday). I believe PVCT could be a good long investment, but it could take several years until you'll see a good profit.
0
0
Ma Kis
Aug 07, 2020 10:10PM ET
Yetkin Belasan In any case wish you a good luck!
0
0
Yetkin Belasan
Aug 07, 2020 1:49AM ET
cause it soo ******cheap.
0
0
Ma Kis
Aug 07, 2020 1:49AM ET
Cheap? Looks like this company almost doesn't have an income, just spending the investors' money.
0
0
Ma Kis
Aug 06, 2020 1:34PM ET
Could someone explain why did the stock price jump so high sharply?
0
0
Ma Kis
Aug 06, 2020 10:52AM ET
What's going on here? No news, no earning reports, but the stock price is up more and more. Just like that, without any reason?!
0
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review